e-therapeutics plc reported earnings results for the half year ended July 31, 2023. For the half year, the company reported sales was GBP 0.16 million compared to GBP 0.295 million a year ago. Net loss was GBP 5.59 million compared to GBP 3.81 million a year ago.

Basic loss per share from continuing operations was GBP 0.0097 compared to GBP 0.0074 a year ago.